The main aim was to explore whether the immuno-inflammatory variables Gal3BP, sCD163, and galectin-3 were independently associated with alexithymia controlling for depression, anxiety, metabolic and life style factors, medication, and cardiovascular complications. This evidence concerns the gene LGALS3 and depressive symptom measurement.